Deborah Brooks, MBA, MS, might not be a scientist but she is using her financial knowledge, business acumen and leadership skills to work towards discovering a breakthrough cure for Parkinson’s disease, a neurological condition that affects seven to 10 million people worldwide.
Deborah, previously vice president in the Fixed Income and Asset Management Divisions at Goldman, Sachs & Co., is a co-founder and executive vice chairman of the Michael J. Fox Foundation for Parkinson’s Research (MJFF), where she serves as a senior adviser on strategic direction and oversees the fundraising, communications and digital strategy teams. She and the MJFF team are working diligently towards finding a cure for the disease and discovering new, more successful therapies by fueling Parkinson’s-related, cutting-edge research initiatives with grant funding.
“To make real progress, we must be strategic, creative, even dogged in problem-solving to overcome our challenges,” says Brooks who, through her undying dedication and exceptional leadership skills, has grown the Foundation from a start-up to the world’s largest private funder of Parkinson’s disease research in just a few years. To date, the Michael J. Fox Foundation for Parkinson’s Research has invested $297 million towards Parkinson’s research funding.
For more information about the upcoming Atlantic Meets the Pacific (TAMTP) Conference (October 7-9, 2012), contact information and list of speakers, please visit the following link: http://www.atlanticmeetspacific.com
To register for the event, please visit: